ML-7 hydrochloride (ML-7 HCl)，又称ML-7盐酸盐，是一种萘磺酰胺衍生物，是肌球蛋白轻链激酶MLCK可逆的、ATP竞争性的抑制剂 (IC₅₀ = 300 nM)。MLCK通路在心血管疾病的发展和I/R损伤中有重要作用。此外，ML-7还可抑制PKA和PKC，K_i值分别为21 μM和42 μM。

参考文献

1.Shi J, et al. Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293cells. Br J Pharmacol. 2007 Sep;152(1):122-31.

2.Yu J, et al. Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation. Int J Med Sci. 2015 Sep 4;12(9):727-36.

3.Luh C, et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J Neurochem. 2010 Feb;112(4):1015-25.

4.Pobbati AV, et, al. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Theranostics. 2020 Feb 18;10(8):3622-3635.

冰袋运输。粉末直接保存于-20℃，有效期2年。建议分装后-20℃干燥保存，避免反复冻融。